1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.08. | ProSomnus Sleep Technologies, Inc.: ProSomnus Sleep Technologies Announces Record Revenues as it Emerges from Reorganization | 177 | GlobeNewswire (Europe) | PLEASANTON, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy, announced record revenues for the quarter... ► Artikel lesen | |
| 05.08. | ProSomnus, Inc. - 15-12G, Securities registration termination | 1 | SEC Filings | ||
| 31.07. | ProSomnus, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.07. | ProSomnus, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| PROSOMNUS Aktie jetzt für 0€ handeln | |||||
| 27.06. | ProSomnus, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.05. | ProSomnus Sleep Technologies, Inc.: ProSomnus Announces Strong First Quarter 2024 Revenue Growth | 224 | GlobeNewswire (Europe) | PLEASANTON, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy, today announced results for the first quarter ended... ► Artikel lesen | |
| 26.03. | ProSomnus Sleep Technologies, Inc.: ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results | 218 | GlobeNewswire (Europe) | PLEASANTON, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea (OSA), today announced financial results... ► Artikel lesen | |
| 22.02. | ProSomnus Sleep Technologies, Inc.: ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea | 213 | GlobeNewswire (Europe) | PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy, announced results of its pilot study... ► Artikel lesen | |
| 29.01. | ProSomnus Sleep Technologies, Inc.: ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices | 376 | GlobeNewswire (Europe) | PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy, announced that the company is well-positioned... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,162 | +1,04 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| NANO-X IMAGING | 6,770 | +3,04 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,075 | +3,71 % | Butterfly Network (NYSE:BFLY) Shares Down 6.3% - What's Next? | ||
| CARMAT | 0,960 | -0,52 % | Successful first "Aeson European User Meeting", marking an important step in the deployment of CARMAT's artificial heart | More than 100 healthcare professionals from 41 hospitals and 10 countries rallied to share their experiences of the Aeson® artificial heart All hospitals taking part in the event confirmed... ► Artikel lesen | |
| GOODRX | 4,450 | -0,89 % | GoodRx stock rises 5% after new CEO appointment | ||
| TALKSPACE | 2,985 | -0,83 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| JOINT CORP | 10,300 | +0,10 % | The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) ("The Joint or "the Company"), the nation's largest franchisor of chiropractic care through The Joint Chiropractic®... ► Artikel lesen | |
| MIMEDX | 9,110 | +0,33 % | MiMedx Group, Inc: MIMEDX Files Patent Infringement Lawsuit Against Surgenex | ||
| PROCEPT BIOROBOTICS | 81,25 | +0,58 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HYPERFINE | 0,885 | -4,73 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| BIOMERICA | 0,275 | +3,46 % | BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| PROGYNY | 14,350 | +1,13 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| ATRICURE | 30,725 | +2,25 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| PROPHASE LABS | 0,630 | -3,54 % | ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline | ||
| AMWELL | 7,860 | +0,38 % | Amwell CFO Mark Hirschhorn takes on expanded role as COO |
Das Unternehmen PROSOMNUS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,13 % bei einem Aktienkurs von 0,480 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROSOMNUS INC finden Sie auf Wallstreet Online.
